The
Mass Spectrometry Unit of the
Center for
Neuroscience and Cell Biology
- University of Coimbra, was established
in 2006 at
Biocant
- Biotechnology Park in Cantanhede, as a
result of a joint effort of the "Molecular
Biotechnology and Health"
research area and the "Neuroprotection
and Cell Death"
research group - CNC-UC. |
The Unit is specialized in the
identification and quantification of proteins from complex samples,
identification of post-translational modifications, and identification and
quantification of metabolites. It is mainly focused on running R&D projects
with partners and collaborators (from CNC, Biocant, other R&D
institutes and private companies). |
Our team has also been involved in
Masters and
PhD courses with the
Chemistry department - UC,
Life Sciences Department of the UC, Faculty of Medicine of UC, CNC-UC, and others,. |
The Mass Spectrometry Unit - Center for Neuroscience and Cell Biology, University of Coimbra,
is member of Portuguese National Mass Spectrometry Network (Rede Nacional de
Espectrometria de Massa). |
|
Since
2006
the Mass spectrometry unit comprised also the Proteomics Unit which
contains own research projects in the field of biomarkers of
oxidative stress, neurodegenerative and neurological disorders |
|
|
|
|
|
|
News and Events |
Check our lattest
publications |
|
|
PDBEB Course
2018/2019 - Proteomics
Approaches in Life Sciences
Cantanhede, 6th - 10th
May
2019 |
|
|
From Protein Structure to Biological Function Through Interactomics: an integrated View,
2nd Edition
Cantanhede, 5th - 9th
February 2018 |
|
Webminar |
Using Microflow LC-MS for Top-Down Sequencing and Bottom-Up Peptide
Mapping |
|
|
Previous international course |
From Protein Structure to Biological Function Through Interactomics: an integrated View
Cantanhede, 7th - 11th September 2015 |
|
In
2015 we received the ISO 9001 under the name "Life Sciences Mass
Spectrometry" |
|
ASMS 2014 interview |
|
In 2014 we became a reference lab for LC-MS applications for Sciex,
the world leading mass spectrometry company. |
|
|
|
|
Sharebiotech interview |
|
|
|
|